‫CS Global Partners: السلفادور، الموطن الأمثل لعملة البيتكوين، هي أحدث دولة تنظر في منح الجنسية عن طريق الاستثمار

لندن، 27 فبراير 2022 (GLOBE NEWSWIRE) – قال الرئيس السلفادوري نجيب بقيلة يوم الأحد إنه سيرسل اقتراحًا إلى الكونجرس لمنح الجنسية للأجانب الذين يستثمرون في الدولة الواقعة في أمريكا الوسطى، ويأتي ذلك بمثابة خطوة أخرى في خطة الزعيم الشعبي لتعزيز اقتصاد بلاده من خلال جذب رأس المال غير التقليدي.

قال بقيلة على تويتر: “أرسل 52 إصلاحًا قانونيًا إلى الكونغرس للتخلص من الإجراءات الروتينية، والحد من البيروقراطية، وإنشاء حوافز ضريبية، ومنح الجنسية مقابل الاستثمارات، وقوانين أوراق مالية جديدة، وعقود استقرار، وغيرها”.

حازت السلفادور، منذ شهر سبتمبر، على اهتمام دولي متزايد عندما أقرت قانونًا بتبني العملة المشفرة البيتكوين كعملة رسمية. واقترح بقيلة هذا القانون لأول مرة ضمن حزمة إصلاحات جديدة في السلفادور.

في حال تمرير الإصلاح القانوني الجديد المتعلق بمنح الجنسية، ستصبح السلفادور واحدة من البلدان القليلة التي توفر برنامج الجنسية عن طريق الاستثمار، وبذلك تنضم إلى العديد من البلدان الصغيرة الأخرى، لا سيما في منطقة البحر الكاريبي، وفقًا لشركة الاستشارات والتسويق الحكومية الرائدة في العالم CS Global Partners.

تتطلب برامج الجنسية عن طريق الاستثمار في العادة من مقدم الطلب الذي يخضع للفحص تقديم الحد الأدنى من المساهمة النقدية لصندوق حكومي أو شراء عقارات في البلد للحصول على الجنسية.

زيادة نطاق حرية الاستثمار في العملات المشفرة في ظل برامج الجنسية عن طريق الاستثمار

تقول ميشا إيميت، الرئيسة التنفيذية لشركة CS Global Partners: “بدأ عدد متزايد من مستثمري العملات المشفرة ورواد الأعمال في مجال التكنولوجيا في البحث عن جنسية ثانية كوسيلة لتحقيق قدر أكبر من الحرية”. وأضافت أن هذه الفئة المتنامية جمعت بين الاستثمار في أصول مثل العملة المشفرة والحصول على جنسيات إضافية لتمكين الاستقلالية المالية وتنوع الثروة.

وأضافت إيميت: “نظرًا إلى اكتساب العملات المشفرة مزيدًا من الزخم في السنوات القليلة الماضية، بدأنا نشهد زيادة في الاهتمام بالحصول على جنسية ثانية من مجتمع المستثمرين في التكنولوجيا. وتُعد هذه الفئة عالمية بالفعل من الناحية التكنولوجية، لذا فمن المنطقي أن يرغبوا في أن تعكس أصولهم طريقة التفكير هذه”.

توفر الجنسية الثانية مستوى من الأمن والأمان يمكن للمستثمرين الاعتماد عليه أثناء حدوث الاضطرابات السياسية أو الاقتصادية، حيث دفع ظهور جائحة كوفيد-19 الأسر بشكل خاص إلى الحصول على جنسية ثانية لحماية أنفسهم وأصولهم المالية بشكل أفضل مع زيادة قدرتهم على التنقل على مستوى العالم.

كانت دولة سانت كيتس ونيفيس التي تتشكل من جزيرتين وجهة شهيرة بين الأثرياء، ويرجع ذلك بشكل أساسي إلى برنامج الجنسية عن طريق الاستثمار الخاص بها. وتوفر هذه المبادرة طريقًا موثوقًا به للحصول على جنسية ثانية بمجرد أن يستثمر مقدم الطلب في البلد. وأُطلق برنامج سانت كيتس ونيفيس عام 1984، وهو معروف دوليًا بالعلامة التجارية “Platinum Standard”.

على الرغم من كون سانت كيتس ونيفيس أصغر دولة ذات سيادة في نصف الكرة الغربي، فهي واحدة من أكثر الدول تقدمًا من الناحية التكنولوجية في المنطقة في ما يتعلق بنهجها في تبني العملات المشفرة في الخدمات المصرفية. وأقرت الجزيرتان مؤخرًا مشروع قانون يبسط تجارة الأصول الافتراضية، كما أنها تنفذ حاليًا برنامجًا تجريبيًا للعملات الرقمية يُعرف باسم DCash. ولا تفرض دولة سانت كيتس ونيفيس أيضًا أي ضريبة على الدخل أو الميراث أو أرباح رأس المال، مما يسمح للمواطنين بالشعور بمقدار أكبر من الحرية أثناء تركيزهم على الاستثمارات التي تشغلهم.

المزيد من الدول تدرس اتخاذ مسار منح الجنسية عن طريق الاستثمار

ليست السلفادور هي البلد الوحيد الذي يتبنى فكرة الجنسية عن طريق الاستثمار لتعزيز اقتصاده. ففي الشهر الماضي فقط، قال وزير الإعلام الباكستاني فؤاد شودري إن الحكومة ستعرض الجنسية الباكستانية على المستثمرين الأجانب، لا سيما كوسيلة لجذب استثمارات ضخمة من الأفراد الأثرياء من دولة الصين المجاورة وباكستان.

يتم حث حكومة جامايكا أيضًا للنظر في تبني برنامج الجنسية عن طريق الاستثمار بالأموال المكتسبة من خلال العملية المستخدمة في مختلف مشاريع التنمية.

أصدرت جوليان ديكسون، الرئيسة التنفيذية ووسيطة لدىJamaica Sotheby’s International Realty، الدعوة في أكتوبر 2021. وقالت إن الأموال المكتسبة من المشروع يجب استخدامها للاستثمار في البنية التحتية والعقارات وخلق فرص العمل وتطوير الأعمال في البلد.

علّقت إيميت، التي تعمل لدى CS Global Partner، قائلة: “بالنسبة لعدد من البلدان، لا سيما في منطقة البحر الكاريبي، لا شك أن برامج الجنسية عن طريق الاستثمار توفر عملية ضخ مهمة للاستثمار الأجنبي المباشر، تتم في الغالب بطريقة يمكن أن تحدث فرقًا تنمويًا كبيرًا. ويتم توجيه هذه الأموال لخفض المساعدات الدولية والديون، وتطوير قطاع السياحة، وزيادة فرص العمل، إذ يقوم الأجانب في كثير من الأحيان بتوظيف السكان المحليين عند توسيع المكاتب أو بناء العقارات، بالإضافة إلى مبادرات الاستدامة”.

أشارت ديسكون بشكل خاص إلى أن سانت كيتس ونيفيس، التي كانت سباقة في تطبيق برنامج الجنسية عن طريق الاستثمار منذ ما يقرب من أربعة عقود واستثمرت ما يزيد على 300 مليون دولار أمريكي من البرنامج في تحديث بنيتها التحتية، وذكرت أن جامايكا يمكنها أن تسير على نفس الدرب.

منتج موثوق 

تقدم سانت كيتس ونيفيس منتجًا موثوقًا نال استحسانًا عالميًا من خلال دراسات مستقلة مثل مؤشر الجنسية عن طريق الاستثمار السنوي الذي تنشره مجلة PWM التابعة لـ Financial Times. وفي ظل تدفق برامج المواطنة في السوق، تستمر سانت كيتس ونيفيس في كونها مركزًا قويًا في الصناعة حيث تحظى بأحد أعرق البرامج القائمة.

يحصل الأشخاص الذين يصبحون مواطنين على كم هائل من المزايا، بما في ذلك زيادة التنقل العالمي إلى المراكز المالية في آسيا وأوروبا وإفريقيا، وتوقعات الأعمال البديلة، والقدرة على نقل الجنسية إلى الأبناء، وبالتالي إنشاء إرث مستقبلي لأسرة الفرد. بالإضافة إلى ذلك، لا تفرض سانت كيتس ونيفيس أي ضرائب على الدخل الشخصي أو الهدايا أو الميراث ولديها عملة مرتبطة بالدولار الأمريكي، مما يجعلها وجهة مربحة ماليًا للمستثمرين المحنكين.

عادةً ما تصدر وحدة الجنسية عن طريق الاستثمار في البلد، التي تقوم بمعالجة كل طلبات الجنسية الاقتصادية، وتصدر الموافقات أو الرفض في غضون فترة تبلغ ثلاثة أشهر. ولا توجد متطلبات تتعلق بإجراء مقابلات أو اللغات أو التعليم أو الأعمال التجارية.

السفر إلى الجزيرة ليس إلزاميًا، ولا يتم تطبيق حد أدنى لمدة الإقامة سواء قبل الحصول على الجنسية أو بعده. وتظل إجراءات العناية الواجبة من بين أكثر الإجراءات صرامة في الصناعة، وتعمل الدولة على تعزيزها من خلال التركيز على تعزيز البصمات والقياسات الحيوية.

في ما يتعلق بمن يتطلعون إلى التحوط ضد المخاطر المستقبلية، فإن الجمع بين السياسات الموائمة للعملات المشفرة والجنسية الثانية في الدولة ذات الجزيرتين يوفر للمستثمرين وثيقة تأمين نهائية في أوقات عدم القدرة على التنبؤ. وتظل سانت كيتس ونيفيس الوجهة الأفضل لتأمين مستقبلك من خلال قطاع خدمات مالية مزدهر ومركز عملات رقمية آخذ في النمو.

تفاصيل الاتصال: pr@csglobalpartners.com, www.csglobalpartners.com / +447824029952

CS Global Partners: Bitcoin Heaven El Salvador Newest Nation to Consider Citizenship by Investment

LONDON, Feb. 28, 2022 (GLOBE NEWSWIRE) — Salvadorian President Nayib Bukele on Sunday said he will send Congress a proposal to grant citizenship to foreigners who invest in the Central American country, another step in the populist leader’s plan to bolster the country’s economy by attracting non-traditional capital.

“I’m sending 52 legal reforms to congress to remove red tape, reduce bureaucracy, create tax incentives, citizenship, in exchange for investments, new securities laws, stability contracts, etc.,” Bukele said on Twitter.

Since September, El Salvador has attracted increasing international interest when it passed a law that made the cryptocurrency Bitcoin legal tender. Like the new package of El Salvador reforms, that law was first proposed by Bukele.

If the new citizenship legal reform is passed, El Salvador would become one of the few countries to offer a citizenship by investment programme, joining several other small countries, mainly in the Caribbean, according to the world’s leading government advisory and marketing firm CS Global Partners.

CBI Programmes usually require a vetted applicant to make a minimum monetary contribution to a government fund or purchase real estate in the country to obtain citizenship.

Greater crypto freedom with CBI

“An increasing number of crypto investors and tech entrepreneurs have started looking to second citizenship as a means of achieving greater freedom”, says Micha Emmett, the CEO of CS Global Partners. She added that this growing demographic has combined assets like cryptocurrency with additional citizenships to unlock financial autonomy and wealth diversity.

“As crypto gained more traction in the last few years, we’ve started seeing an increase in interest for second citizenship from the tech community. This demographic, technologically, is already global, so it makes sense that they want their assets to reflect this mindset,” she said.

A second citizenship offers a level of safety and security that investors can rely on during political or economic turmoil. The onset of the COVID-19 pandemic has particularly triggered families to obtain second citizenship to better protect themselves and their financial assets whilst increasing their global mobility.

The dual-island nation of St Kitts and Nevis has been a popular destination amongst the wealthy, mainly because of its CBI Programme. This initiative provides a trusted route to second citizenship once an applicant invests in the nation. Established in 1984, St Kitts and Nevis’ programme is internationally recognised as a ‘Platinum Standard’ brand.

Despite being the smallest sovereign state in the Western Hemisphere, St Kitts and Nevis is one of the most technologically advanced nations in the region regarding its crypto-friendly approach to banking. The islands recently passed a bill simplifying the trade of virtual assets and are also currently running a digital currency pilot programme known as DCash. St Kitts and Nevis also does not impose income, inheritance, or capital gains tax, allowing citizens to breathe a little freer as they focus on the investments that matter to them.

More countries are considering the CBI route

El Salvador is not the only country tossing with the idea of citizenship by investment to boost its economy. Just last month, Pakistan’s Information Minister Fawad Chaudhry said that the Government would offer Pakistani nationality to foreign investors, particularly as a way to recruit heavy investments from the wealthy individuals of neighbouring China and Pakistan.

Jamaica’s Government is also being pushed to consider adopting a citizenship by investment programme with the funds gained through the process used for various development projects.

Julian Dixon, CEO and broker at Jamaica Sotheby’s International Realty, made the call in October 2021. She said funds gained from the project should be used to invest in the country’s infrastructure, real estate, job creation and business development.

“For a number of countries, especially in the Caribbean, there is no denying that CBI programmes offer a much-needed injection of foreign direct investment, often in a way that can make a significant developmental difference. These funds are channelled into reducing international aid and debt, developing the tourism sector, job growth as foreigners often employ locals when expanding offices or constructing properties, and sustainability initiatives,” CS Global Partner’s Emmett commented.

Dixon particularly pointed out that St Kitts and Nevis, which pioneered the citizenship by investment programme close to four decades ago and has invested upwards of US$300 million from the programme in modernising its infrastructure. She said Jamaica could do the same.

A trusted product 

St Kitts and Nevis offers a trusted product that has been acclaimed globally by independent studies like the annual CBI Index published by the Financial Times’ PWM magazine. With an influx of citizenship programmes on the market, St Kitts and Nevis continues to be a powerhouse within the industry with one of the longest-standing programmes in operation.

Those who become citizens gain a wealth of benefits, including increased global mobility to financial centres in Asia, Europe and Africa, alternative business prospects, and the ability to pass citizenship down, thus establishing a future legacy for one’s family. Additionally, St Kitts and Nevis does not impose any personal income, gift or inheritance tax and has a currency pegged to the US dollar, making it a financially lucrative destination for savvy investors.

The country’s CBI Unit, which processes all economic citizenship applications, usually issues approvals or denials within a period of three months. There are no interviews, language, education, or business requirements.

Travel to the island is not obligatory, and no minimum residence stays apply either before or after Citizenship is obtained. Due diligence procedures remain among the industry’s most robust, and the nation is strengthening them by focusing on enhancing fingerprinting and biometrics.

For those looking to hedge against future risks, combining the dual-island nation’s crypto-friendly policies and second citizenship provides investors with the ultimate insurance policy during times of unpredictability. St Kitts and Nevis remains the best destination for securing your future with a thriving financial services sector and a growing crypto hub.

Contact: pr@csglobalpartners.comwww.csglobalpartners.com / +447824029952

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – AFIB

NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”) of the important April 18, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Acutus Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Acutus Medical class action, go to https://rosenlegal.com/submit-form/?case_id=3255 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 18, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) a material percentage of the AcQMap systems under evaluation had been randomly installed at sites with little, if any, consideration given to whether the healthcare providers at the selected locations were likely to adopt, or desire, Acutus Medical’s products; (2) a material percentage of the AcQMap systems under evaluation had been installed in locations where Acutus Medical did not possess the infrastructure necessary to appropriately educate, train, and support medical service providers on the system’s operations; (3) as a result, Acutus Medical was in the process of designing a strategic plan to terminate and relocate approximately 20% of then-existing AcQMap systems evaluation arrangements; (4) Acutus Medical’s management discussion and analysis was materially false and misleading and failed to disclose that the termination and relocation of approximately 20% of existing AcQMap systems evaluation arrangements was reasonably likely to have a material adverse effect on Acutus Medical’s 2021 financial results; and (5) Acutus Medical’s risk factor discussions were materially false and misleading and made reference to potential risks without disclosing that such risks were then-existing or adequately describing the specific nature of the risks then facing Acutus Medical. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Acutus Medical class action, go to https://rosenlegal.com/submit-form/?case_id=3255 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

ROSEN, A TOP RANKED LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – FENC

NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive (the “Class Period”) of the important April 11, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Fennec Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Fennec Pharmaceuticals class action, go https://rosenlegal.com/submit-form/?case_id=3153 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Fennec Pharmaceuticals had not successfully remediated, and overstated its efforts to remediate, issues with the manufacturing facility of its drug product manufacturer for PEDMARK; (2) as a result, the U.S. Food and Drug Administration was unlikely to approve the Resubmitted PEDMARK New Drug Application (“NDA”); (3) accordingly, the regulatory and commercial prospects of the Resubmitted NDA were overstated; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Fennec Pharmaceuticals class action, go https://rosenlegal.com/submit-form/?case_id=3153 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

Chinmay J. Upadhyat becomes Regional Vice President, South Asia for Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, announces that Chinmay J. Upadhyat has joined the Group as Regional Vice President, South Asia region.

Chinmay will be based in Nikkiso Cosmodyne India Private Ltd, their large manufacturing and competence center in Gujarat India.

This important addition to their management team is the result of growth in the market environment and is in line with the objectives of the Industrial Division of Nikkiso to better serve and support their customers in the Southern Asia Market.

Chinmay started his career in 1995 as a Production Engineer with Anup Engineering and Inductotherm India, then served as key account manager for ten years with Dresser Rand India. Since 2008 he has been Regional then Assistant General Manager for Burckhardt Compression India where he was responsible for sales and business development of new machines for the Indian market.

With his broad experience in the CNG, LNG, H2 and industrial gas markets in India, Chinmay will lead the Nikkiso Clean Energy & Industrial Gases sales and service teams in this important region and embark on a mission to deliver market share growth in a sustainable and profitable way.

“Chinmay will be a perfect addition to our management team with his proficiency in business development, equipment, service, aftermarket sales and market knowledge,” according to Emile Bado, Vice President, Sales & Business Development of the Group.

Chinmay has a Mechanical Engineering degree from Government Polytechnic, Ahmedabad, a Bachelor’s in Technology from JNRVD University, Rajasthan and an MBA from Sikkim Manipal University in Manipal.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information please visit www.cryoind.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Provation appoints Gulf Medical Company as exclusive partner in Saudi Arabia for its market-leading clinical productivity solution

Provation® MD allows clinicians around the world to quickly and accurately document procedures electronically for gastroenterology and respiratory procedures.

Jeddah, Saudi Arabia, and Minneapolis, Minn., USA, Feb. 24, 2022 (GLOBE NEWSWIRE) — Provation, the premier software provider of procedure documentation and clinical decision support solutions, today announced an exclusive partnership with Gulf Medical Company, Ltd., a market leader in medical device and software distribution. The partnership agreement allows Gulf Medical to sell and distribute the global Gold Standard of gastroenterology (GI) and respiratory procedure documentation software, Provation® MD, throughout the Kingdom of Saudi Arabia (KSA).

For more than 25 years, Provation has been a market leader in clinical productivity software. Every day, more than 15,000 physicians and endoscopists in over 5,000 healthcare facilities worldwide use its intuitive workflows, image capture, and deep medical content for gastroenterology and respiratory documentation. Provation MD integrates with existing hospital information systems to replace paper clinical documentation, while improving the consistency, accuracy, and efficiency of procedure notes.

“Gulf Medical looks to its partnership with Provation as a milestone in our diversification into the healthcare IT business stream, which aligns with the Saudi government’s 2030 vision for digitization and Gulf Medical’s vision in bringing the most innovative solutions to the Middle East since 1983,” said Mohamed A. Raouf, Director of Services and New Technologies at Gulf Medical. “As a market leader in its domain, Provation can shift our customers’ experience into a new era of facilitating electronic documentation and reporting and GI workflow management.”

Provation awarded the partnership to Gulf Medical because of its excellent reputation and strong customer relationships with both the private and public hospital sectors throughout the region.

“We are very excited to have Gulf Medical as the exclusive distributor of Provation MD in Saudi Arabia,” said Daniel Hamburger, CEO of Provation. “The Gulf Medical team knows the medical device and software needs of healthcare organizations in their region. This partnership will allow us to further expand Provation’s presence throughout the Kingdom, while empowering more clinicians and endoscopists with the tools they need to deliver quality healthcare for all.”

Gulf Medical plans to rapidly introduce Provation MD to leading healthcare facilities across the Kingdom of Saudi Arabia (KSA).

About Provation

Provation is a leading provider of healthcare software and SaaS solutions for clinical procedure reports, anaesthesia documentation, quality reporting, and more. Provation is best known globally for providing the Gold Standard for gastroenterology (GI) procedure documentation, Provation® MD, and #1 Best in KLAS anaesthesia information management system, Provation® iPro. Our purpose is to empower providers worldwide with the tools they need to deliver quality healthcare for all.

Provation serves more than 5,000 hospitals and health systems, surgery centres, and medical offices, and 700 physician groups worldwide. In 2021, Provation was acquired by Fortive Corporation, a Fortune 1000 company that builds essential technology and accelerates transformation in high-impact fields like workplace safety, engineering, and healthcare. For more information about our solutions, visit provationmedical.com.

About Gulf Medical Company, LTD

Gulf Medical Co. was founded in 1983 to bring the most innovative medical solutions to the Middle East. It is owned by Al-Naghi Group (since 1911) and it serves the medical field in different product lines, bringing many firsts in medical solutions to the region; with a core value that its service does not end at the award of a sale; but only begins at the award and continues for many years to come after, this is side by side to customers and patients. Learn more at www.gulfmedical.com.

Attachment

Tristan Galvan
Provation
612.313.1548
tristan.galvan@provationmedical.com

Eng. Hamza Sheikh
Gulf Medical Company
hamzasheikh@gulfmedical.com